Exenatide vs Trastuzumab

Exenatide vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Exenatide and Trastuzumab.

Mechanism of Action

Exenatide: Synthetic exendin-4 GLP-1 receptor agonist enhancing glucose-dependent insulin secretion.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Exenatide — 2.4 hours; Trastuzumab — 28 days.

Chemical Properties

Type: Exenatide — Protein; Trastuzumab — Antibody.